{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "## Necessary libraries\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Preprocessing\n",
    "\n",
    "- Eliminar els asteriscos\n",
    "- Juntar els punts que estan separats per un espai del final de la paraula"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import re\n",
    "\n",
    "def clean_text(text):\n",
    "    # Replace all groups of asterisks with a single space\n",
    "    text = re.sub(r\"\\*+\", \" \", text)\n",
    "    \n",
    "    # Replace multiple spaces with a single space and strip leading/trailing spaces\n",
    "    text = re.sub(r\"\\s+\", \" \", text).strip()\n",
    "    \n",
    "    # Fix spacing before punctuation\n",
    "    text = re.sub(r\"\\s+([.!?])\", r\"\\1\", text)\n",
    "    \n",
    "    return text\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### ASHO SUMMARIES"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "asho_summaries = pd.read_json(r'C:\\Users\\xavim\\Desktop\\NLP project\\NLP_project.json')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "asho_summaries['Text'] = asho_summaries['Text'].apply(clean_text)\n",
    "asho_summaries['Summary'] = asho_summaries['Summary'].apply(clean_text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "sorted_indices = asho_summaries['Summary'].str.len().sort_values(ascending=False)\n",
    "text_with_summaries = sorted_indices[sorted_indices > 10]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "12    1020\n",
       "6     1015\n",
       "5      876\n",
       "7      859\n",
       "4      793\n",
       "13     658\n",
       "9      215\n",
       "8      166\n",
       "10     130\n",
       "11     103\n",
       "Name: Summary, dtype: int64"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_with_summaries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "asho_summaries_sorted = asho_summaries.iloc[sorted_indices.index]\n",
    "train_data = asho_summaries.iloc[text_with_summaries.index]\n",
    "train_data = train_data.reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Id</th>\n",
       "      <th>Summary</th>\n",
       "      <th>Text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1006079393</td>\n",
       "      <td>Paciente mujer de 80 años que ingresa proceden...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1006960152</td>\n",
       "      <td>Paciente que ingresa por hematemesis y pérdida...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1006962381</td>\n",
       "      <td>Paciente que ingresa por pérdida del conocimie...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1006956131</td>\n",
       "      <td>Paciente de edad avanzada e ingresos frecuente...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1006949703</td>\n",
       "      <td>Paciente que ingresa por deterioro de estado g...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>1006075221</td>\n",
       "      <td>Paciente varón de 79 años que ingresa proceden...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>1006079393</td>\n",
       "      <td>Estudio de muestra histológica procedente de i...</td>\n",
       "      <td>servicio anatomia patologica , dr/dra: muestra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>1006568506</td>\n",
       "      <td>Paciente con ingreso programado para coronario...</td>\n",
       "      <td>diagnostic alta codi icd-10 descripcio diagnos...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>1006079393</td>\n",
       "      <td>Exámen de muestra histológica de intestino del...</td>\n",
       "      <td>servicio anatomia patologica , dr/dra: muestra...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>1006076158</td>\n",
       "      <td>Estudio celular de líquido ascitico que muestr...</td>\n",
       "      <td>servicio anatomia patologica , dr/dra: muestra...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "           Id                                            Summary  \\\n",
       "0  1006079393  Paciente mujer de 80 años que ingresa proceden...   \n",
       "1  1006960152  Paciente que ingresa por hematemesis y pérdida...   \n",
       "2  1006962381  Paciente que ingresa por pérdida del conocimie...   \n",
       "3  1006956131  Paciente de edad avanzada e ingresos frecuente...   \n",
       "4  1006949703  Paciente que ingresa por deterioro de estado g...   \n",
       "5  1006075221  Paciente varón de 79 años que ingresa proceden...   \n",
       "6  1006079393  Estudio de muestra histológica procedente de i...   \n",
       "7  1006568506  Paciente con ingreso programado para coronario...   \n",
       "8  1006079393  Exámen de muestra histológica de intestino del...   \n",
       "9  1006076158  Estudio celular de líquido ascitico que muestr...   \n",
       "\n",
       "                                                Text  \n",
       "0  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "1  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "2  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "3  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "4  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "5  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "6  servicio anatomia patologica , dr/dra: muestra...  \n",
       "7  diagnostic alta codi icd-10 descripcio diagnos...  \n",
       "8  servicio anatomia patologica , dr/dra: muestra...  \n",
       "9  servicio anatomia patologica , dr/dra: muestra...  "
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"diagnostic alta codi icd-10 descripcio diagnostic i50.1/2 insuficiencia cardiaca esquerra dades informe motivo de ingreso mujer de 80 años que ingresa por disnea. antecedentes personales: alergia a contrastes yodados. - hta en tratamiento farmacologico. - dm tipo 2 en tratamiento con insulina - fa paroxistica anticoagulada con acod y en estratetgia de control de ritmo con amiodarona. - cirrosis hepatica secundaria a vhc. trasplante hepatico en 2009. controlada por aparato digestivo (dr castellote). trasplante hepatico en 2009. octubre 2012, se retira advagraf (tacrolimus) -por nefrotoxicidad y se mantiene micofenolato. - nefropatia diabetica y nefropatia por iga. transplante renal en 2013. en tractamiento inmunosupresor con ciclosporina y micofenolato. control en ccee de nfr. actualmente en tratamiento inmunosupresor con rapamune 1mg/dia. - varios episodios de pielonefritis del injerto renal. ultimo ingreso sep/15 por pielonefritis aguda por e. coli blee. tratamiento conertapenem 1 g/ 24 h hasta completar 2 semanas del mismo. - criterios de bronquitis cronica. multiples sobreinfecciones respiratorias que requieren ingreso en la uceu. - carcinoma escamoso de punta nasal intervenido en 2018. - fractura vertebral l1 osteoporotica. qx: intervenida de ligamentos cruzados de rodilla derecha por fractura posterior a accidente de trafico. transplante hepatico en 2009, colecistectomia protesis de cadera izda. trasplante renal 2013. vgi : funcional: movilizacion en silla de ruedas. minima deambulacion para minimas tranferencias con una muleta.; mental: consciente, orientada, colabora; social: actualmente en tratamiento actual : cellcept 250mg /12h, amiodarona 200mg cada 8h, amlodipino 5mg cada 24h., atorvastatina 40mg cada 24h., carvedilol 6.25mg 1.5comp/12h.,lormetazepam 1mg 0-0-0-1, apixaban 2.5mg cada 12h., furosemida 40mg 1 comp /24h., vesicare 5mg 1-0-0, omeprazol 20mg 1-0-0, paracetamol 1g/8h, losartan 50/12.5mg cada 24h, lantus 28.0.0, omperazol 20mg cada 24h. enfermedad actual mujer de 80 años que refiere disnea que se hace progresivamente de minimos esfuerzos, sin clara ortopnea ni episodios de disnea paroxsitica nocturna. explica astenia marcada, rinorrea y congestion nasal y tos seca de 1 semana de evolucion. en este contexto presento el domingo episodio de palpitaciones autolimitadas sin dolor pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 1 de 8 informe alta hospitalitzacio toracico ni otra clinica añadida. niega fiebre ni sensacion distermica. edemas en miembros inferiores de predominio verpertino que mejoran con el decubito. niega trasgresiones dieteticas claras, explicando que tan solo come lo que le dan en la residencia con el aporte hidrico de siempre y sin bebidas carbonatadas o alimentos ricos en sal. en la atencion en hub al que es derivado el 14.11 objetivan insuficiencia respiratoria (sin gsa disponible, pero con hipoxemia con necesidad de vmk 0.26 para mantener spo2 &gt;95%), rx de torax con infiltrado alveolointersticial bilateral de predominio en bases con hilios engrosados y patron hiliofugal bilateral que junto con bnp alto sugieren fallo cardiaco. minima elevacion de rfa con anemia ya conocida sin cambios. ademas presenta episodio de hipoglicemia que remonta con glucosomon, siendo este el 4º, los 3 ultimos en la ultima semana. exploracion fisica en planta de mi 17.11.2021 pa:174/64 mmhg fc: 80 lpm. tª: 35.4ºc. glicemia 208mg/dl. sato2 96% cn2l. consciente y orientada. tinte subicterico. normohidratada. eupneica y bien perfudndia. acr ruidos irregulares sin soplos ni roces. murmullo vesicular conservado con crepitantes finos en base izquierda y mas gruesos en base derecha. no iy ni rhy. sin edemas en miembros inferiroes ni signos de trombosis venosa profunda. abdomen blando y depresible sin dolor a la palpacion ni signos de irritacion peritoneal. no palpo masas ni megalias. peristaltismo conservado. neurologicamente sin focalidad aguda. exploraciones complementarias ecg : rs. 70 lpm. eje -30º. dei. bav 1º pr 0.28. qrs 0.08. sin alteraciones agudas en la repolarizacion. rx de torax : ict &gt; 0.5. infiltrados intersticiales bilaterals de predominio central, hiliofugales con derrame pleural asociado y mayor respecto a rx previos todo ello sugestivo de fallo cardiaco. tira y sedimento de orina negativos.. hemocultivos negativos. pcr virus respiratorios: indetectables. analitica rutina 17.11: vsg 79mm/h, leucocitos 7410/mm3, n 5760/mm3, l 1070/mm3, e 20/mm3, hb 10.8g/dl, hto 0.34, vcm 91fl, hcm 29pg, pqt 251000/mm3, inr 1.36 (tp: 60%), ttpar 34s, glucosa 201mg/dl, hba1c 5.3%, tg 208mg/dl, ct 137mg/dl, hdlc 28mg/dl, nohdl 108mg/dl, ac urico 5.7mg/dl, cr 125umol/l, fge 34ml/min, urea 72mg/dl, na 137meq/l, k muestra hemolizada, mg 0.84mg/dl, bt 0.62mg/dl, ast 63u/l, alt 26u/l, fa/ggt: 92/108u/l, p/a: 67/34g/l. fe 24ug/dl, ferritina 50ug/l, transferrina 2.06g/l, ist 8%, b12 431pmol/l, folatos 34nmol/l. tsh 0.12 mu/l, t4l 30pmol/l. calcidiol : 25.8ng/ml. proteinograma. a 52%, a1 7%, a2 18%, g g 10.7%. ratio a/g: 1.09. analitica de control 19.11: leucocitos 7250/mm3, n 5140/mm3, hb 10.1g/dl; hto 0.32, vcm 91fl, hcm 29pg, pqt 254000/mm3, inr 1.42 (tp 56%), ttpar 1.12, cr 131umol/l, fge 33ml/min, urea 110mg/dl, na 141meq/l, k 4.6meq/l, calcio 8.7mg/dl, p 4.3mg/dl, bt 0.49mg/dl, ast/alt 12/16u/l, fa/ggt: 78/70u/l, a 32g/l. cks 39u/l, prealbumina 0.2. analitica de control 23.11: leucocitos 6280/mm3, n 4130/mm3, l 1400/mm3, hb 9.2g/dl, hto 0.3, vcm 91fl, hcm 28pg, pqt 218000/mm3, inr 1.34 (tp: 64%), ttpa 29s. cr 137umol/l (previo 131), fge 31ml/min, urea 115mg/dl, na 143meq/l, k 4.1meq/l, bt 0.65mg/dl ast/alt 17/19u/l, fa/ggt: 71/51u/l, a 30g/dl, ntprobnp 2662 (previo de 4715pg/ml). pcr 21mg/l (previa de 15). iones en orina 2h despues del bolus de furosemida: na 71mmol/l, k 36mmol/l, cl 75.9mmol/l. analitica de control 24.11: cr 141umol/l, fge 30ml/min, urea 119mg/dl, na 139meq/l, k 4.1meq/l. ldh 190u/l pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 2 de 8 informe alta hospitalitzacio (n), b2m 8.8 (elevada en contexto de erc), iga e igm normales, igg bajas (675mg/dl). tnius 5ng/l (negativas). cadenas kappa 33.6; cadenas lambda 29.1. ratio 1.155 (n). serologias de atipicas: legionellla negativa, coxiella burneti igg/m negativas, chlamydia pneumoniae igg positiva con igm negativa, chlamydia psittaci igg e igm negativas. pcr cmv: indetectable. ca-125: 364u/ml. inmunifijacion de cadenas libres en orina sin anormalidades evidentes. analitica de control 02.12: leucocitos 6660/mm3, n 4800/mm3, l 1280/mm3, hb 8.8g/dl, hto 0.27, vcm 89fl, hcm 29pg, pqt 207000/mm3, inr 1.14 (tp: 79%), ttpar 1.01, cr 157umol/l, fge 26ml/min, urea 230mg/dl, na 132meq/l, k 4meq/l, a 31g/l, pcr 17mg/l. analitica control 09.12 leucocitos 12810/mm3, n 11120/mm3, l 980/mm3, e 20/mm3, hb 8.9g/dl, hto 0.27,m vcm 88fl hcm 29pg, pqt 215000/mm3, cr 150umol/l, urea 43mg/dl, fge 28ml/min, na 128meq/l, k 3.7meq/l, ntprobnp 5207pg/ml gsa basal 10.12: ph 7.44, pco2 33mmhg, po2 56mmhg, hco3 23mmol/l, o2 91%. serologias agshb, anti-shb y anticore hb negativos. vih negativo. serologias vhc positivas: rna-vhc indetectable. tc de torax s/c 22.11: no se aprecian adenopatias supraclaviculares, axilares ni mediastinicas. cardiomegalia. ateromatosis coronario-aortica calcificada. arteria pulmonar de calibre normal, limitrofe. derrame pleural bilateral moderado y de baja densidad, con atelectasia pasiva del parenquima subyacente. no se aprecian consolidaciones parenquimatosas ni nodulos pulmonares de clara sospecha. opacidades seudonodulares subpleurales con tractos parenquimatosos asociados, parcialmente trigonales en ambos llii, de hasta 16 mm en segmento 6 izquierdo, inespecificas, de probable etiologia atelectasica (redonda), a controlar tras resolucion de cuadro agudo en al menos 6 meses. discretos infiltrados en vidrio deslustrado y finas opacidades intersticiales en llss y muy fino engrosamiento peribronquial, de probable etiologia infecciosa/inflamatoria, sin consolidaciones parenquimatosas establecidas. no se objetiva engrosamiento significativo de septos. no derrame pericardico. signos degenerativosgeneralizados con espondilosis dorsal, sin identificarse imagenes que sugieran lesiones secundarias. ecografia abdominal 22.11: higado de tamaño en el limite superior de la normalidad, con ecoestructura homogenea y pequeños granulomas calcificados, sin otras lesiones focales evidentes. vena porta permeable con flujo hepatopetal. colecistectomia. ectasia leve de via biliar intra y extrahepatica, sin causa obstructiva evidente. pancreas parcialmente visualizado, sin alteraciones evidentes. bazo homogeneo y de tamaño normal con algunos granulomas calcificados. riñones nativos atroficos (rd de 6.5 cm y ri de 7 cm), sin dilatacion de las vias excretoras. injerto renal localizado en fid de 12.1 cm, con tamaño, morfologia y ecoestructura preservadas. muestra una correcta curva doppler arterial y venosa, con indices de resistencia ligeramente aumentados en torno a 0.90. vejiga urinaria muy replecionada, sin alteraciones valorables. no se observa liquido libre intraabdominal. ett 23.11: ventricle esquerre no dilatat, moderadament hipertrofic (tiv 15mm) amb funcio ventricular conservada (fe per simpson 57%), sense alteracions en la contrac??litat segmentaria. auricula esquerre severament dilatada (volumindexat 52ml/m2). valvula mitral amb els vels esclerosats , amb obertura conservada i insuficiencia lleugera (grau i). arrel aor??ca no dilatada. valvula aor??ca trivalva amb vels esclerosats obertura conservada i sense insuficiencia. ventricle dret no dilatat, normcontrac??l. no es detecta prou señal d#it que perme?? el calcul de la paps; fluxe d#arteria pulmonar no sugges??u d#augment de les resistencies vasculars pulmonars. alteracio diastolica??pus iii (ona l en patro transmitral). e/a: 2.28. sense vessament pericardiac. vena cava inferior no dilatada. pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 3 de 8 informe alta hospitalitzacio gammagrafia osea 26.11: el estudio realizado no muestra captacion valorable del hmdp en area cardiaca, y no hay evidencia de una enfermedad por deposito cardiaco como una amiloidosis de tipo ttr. considerando la utilizacion del trazador de gammagrafia osea, en relacion al rastreo oseo efectuado, destacamos un patron osteoporotico/osteomalacico involutivo senil severo y poliarticular degenerativo cronico evolucionado, con rectificacion cifoescoliotica dorsolumbar, multiples fracturas costocondrales de disposicion alineada y de etiologia osteopenica/postcontusional en la parrilla costal anterior derecha, asi como fractura por aplastamiento vertebral de la misma etiologia en la plataforma superior de l4. no hay captaciones significativas asociadas a la ptci sugestivas de movilidad/aflojamiento. como hallazgo extraoseo observamos injerto renal en fosa pelviana derecha, ausencia de visualizacion de ambas siluetas renales en situacion ortotopica (irc terminal) y discreta fijacion difusa del trazador en parenquima hepatico que puede ser de tipo artefactual/tecnico por formacion indeseada de coloide en el radiofarmaco, o por el contexto clinico de la paciente. discreta fijacion del trazador en partes blandas de la mama izquierda, a valorar de forma dirigida. en los otros hallazgos valorables en el rastreo oseo efectuado. conclusiones: estudio negativo para la deteccion de una amiloidosis cardiaca. patron osteoporotico /osteomalacico severo y poliarticular degenerativo cronico con multiples fracturas costocondrales en parrilla anterior derecha, asi como en l4, sin evidencia de patologia osea tm. infiltrativa o metastasica con actividad osteogenica. injerto renal en fosa pelviana derecha. gammagrafia pulmonar de perfusion 14.12: distribucion homogenea de los macroagregados por el lecho vascular de ambos pulmones, destacando una rectificacion de la base pulmonar izquierda, elevada, y no se observan defectos de perfusion perifericos de caracter segmentario ni subsegmentario sugestivos de tep ni de una lesion ocupante de espacio intraparenquimatoso con compromiso significativo de la vascularizacion pulmonar en la actualidad. marcada impronta de la silueta cardiaca. los valores obtenidos en la cuantificacion de la perfusion son los siguientes (media geometrica de las proyeciones anterior y posterior): izquierdo derecho total: 46.9% 53.1%; superior: 10.0% 12.3%; medio: 27.0% 25.2%; inferior: 9.9% 15.6%; conclusiones: no hay imagenes sugestivas de tep en la gpp obtenida. elevacion/rectificacion de la base pulmonar izquierda, a valorar en el contexto rx. fcn 23.11: mala preparacion. escala de boston: colon derecho: 0, transverso: 0, izquierdo: 0. global: 0; colonoscopia: se explora todo el colon hasta ciego procediendo a su intubacion. valvula ileocecal de caracteristicas normales. abundantes restos fecales que impiden la correcta valoracion de la mucosa. no obstante no se intuyenlesiones. la mucosa que se consigue explorar es de caracteristicas normales. se toman biopsias en colon derecho (1) e izquierdo (2). mala preparacion intestinal. debe considerarse la exploracion no valorable. procedimientos: biopsias. complicaciones: ninguna. diagnostico: colonoscopia no valorable. biopsias. pendiente histologia. fgc 23.11: mucosa esofagica sin lesiones. hernia de hiato poaraesofagica no compllicada. estomago: lago mucoso sin productos patologicos. fundus normal por retroversion. cuerpo con pliegues y mucosa de aspecto normal. incisura sin lesiones. antro sin lesiones. piloro: sin lesiones. duodeno: bulbo y segunda porcion duodenales sin lesiones. se toman biopsias. procedimientos: biopsias. complicaciones: ninguna. diagnostico: hernia de hiato pequeña. biopsias. pendiente histologia. capsula endoscopica : informe pendiente al alta ap: bx duodenal : mucosa duodenal de morfologia dentro de los limites de la normalidad. ap bx colon: pendiente al alta. evolucion pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 4 de 8 informe alta hospitalitzacio mujer de 80 años, alergica a contrastes yodados, con ap de hipertension, dm tipo 2 insulinizada, hiperlipemia, fiba paroxistica anticoagulada con acod, ait en 2016 con estenosis carotidea significativa (se desestimo tratamiento qx), trasplantada hepatica desde 2009 por cirrosis hepatica por vhc (controles semestrales hub), trasplantada renal desde 2013 por nefropatia iga + dm (controles semestrales hub), pielonefritis del injerto renal en 2014 y dos episodios en 2015, hiperreactividad bronquial, osteoporosis, carcinoma escamoso de punta nasal intervenido en 2018. infeccion de orina reciente (octubre de 2021) tratada 7 dias con cefuroxima. institucionalizada en residencia vitalia. funciones superiores conservadas. transferencias en silla de ruedas tras accidente de trafico hace años con fractura e intervencion rodilla derecha. parcialmente dependiente para abvd y aivd. ingresa en medicina interna con el diagnostico principal de insuficiencia cardiaca y presenta la siguiente evolucion por problemas: insuficiencia cardiaca aguda con fep. disfuncion diastolica grave con patron de disfuncion diastolica restrictivo. posibles desecadenantes tendrian anemia ferropenica de la que se ha descartado perdida digestivas por fgc y fcn a falta de resultados de capsula endoscopica y de la biopsia colonica ferropenica y secundaria a erc por la que ha recibido 1g de cxm y se ha iniciado epo durante el ingreso. hipertiroidismo por amiodarona tipo 2. suspension del tratamiento diuretico y neurohormonal 1 mes antes del inicio de sintomas. durante el ingreso, ha presentado importantes dificultades para mejorar la congestion pulmonar dada la compensacion incompleta de los factores que atribuimos como desencadenantes principales (anemia e hipertiroidismo). a mediados del ingreso, intento fallido de paso de la medicacion diuretica a via oral, que obliga a intensificar de nuevo el tratamietno diuretico endovenoso por aumento de peso y de la hipoxemia. con tal de optimizar los factores que se consideran desencadenantes, se inicia epo para mejorar la anemia una vez descartadas perdidas digestivas y prednisona 45mg/dia ademas de tirodril como tratamiento del hipertiroidismo por toxicidad por amiodarona tipo 2. aproximadamente 2 semanas despues, presenta una mejoria clinica que permite pasar de nuevo el tratamiento a via oral. se decide dado el ingreso prolongado y la estabilidad clinica en los ultimos dias con estabilidad del peso (58kg) y la mejoria de la hipoxemia, necesitando colocacino de o2 a 0.5l a ratos durante el dia continuar la evolucion en residencia con soporte de hado para aseguara optimizacion del tratamiento y estabilidad clinica al alta. insuficiencia respiratoria aguda en relacion con insuficiencia cardiaca aguda. durante el ingreso ha presentado dificultades para mejorar la oxigenacion. se ha completado el estudio con tc de torax que muestra derrame pleural bilateral con atalectasia pasiva de parenquima subyacente y opacidades pseusonodulares subpleural con tractos parenquimatosos asociado inespecificas de etiologia atelectasica que se atrobuyen tras comentarlo con neumologia y considerendo la cifoescolisosis que presenta al cuadro de insuficiencia cardiaca. aun asi se programara tc de torax de control en 6 meses para control de las imagenes descritas. ademas se ha descartardo infecciones por germenes atipicos por serologias, incluida pcr de cmv en sangre negativa asi como tep con g v/p negativa. al alta queda con spo2 oscilantes entre 92-97% que mejoran con la inspiracion profunda. por confort y de cara a la retirada progresiva se acuerda con neumologia dejar oxigenoterapia a bajos flujos (0.5l) a demanda en residencia hasta asegurar la correcta resolucion del cuadro. fracaso renal agudo sobre ercg3b-4. revisando los cursos de nfr de hub (seguimiento tr) presenta de forma habitual cr 120umol/l en fase estable. en abril'2021 empeoramiento sin causa aparente hasta de 161umol/l. en pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 5 de 8 informe alta hospitalitzacio septiembre anl abs con cr 213umol/l. fue derivada por ese motivo a urg-hub en octubre'2021 donde se constato cr 210umol/l y se oriento como secundario a itu no febril y excesiva medicacion depletiva por lo que se trato empiricamente con cefuroxima 500mg 1-0-1 y se indico retirar losartan e hctz y dismiuir furosemida a 0.5comp/dia. con esta pauta ingresa con nosotros a mediadios de nov por insuficiencia cardiaca aguda. al ingreso cr 1.3mg/dl y al alta de 1.8mg/dl. pensamos que la descompensacion cardiaca este provocada por la interrupcion del tto.neurohormonal y diuretico 1 mes antes y que ahora presenta deterioro de la funcion renal en contexto de la medicaciondiuretica y antihta asumible, siempre y cuando no exceda la cr actual. hipertiroidismo tipo 2 inducido por amiodarona. tiroiditis destructiva, actualmente en tto. con tirodril y pdn de 45mg/dia por persistencia de tsh bajas pese al tratamiento con tirodril. se completa el estudio con autoinmunidad, negativa y ecografia de tiroides sin hallazgos de interes. ya que se preve tratamiento con dosis alta de cortisona de forma prolongada y ante el ac. de th y tr se evalua el estado serologico de vhb y vhc con agshb negativo e igg-vhc positiva con rna-vhc indetectable lo que revela inmunidad natural frente a la infeccion pasada. aun asi se consideran dosis altas por lo que tras comentarlo con la unidad de virlogia se inicia cotrimoxazol a dosis intermedias 80/400 l-x-v hasta que la dosis de pdn sea &lt; 15mg/dia. se evaluara la funcion renal una vez empezado este tratamiento. en relacion a los corticoides presenta hiperglicemias simples complejas de controlar durante el ingreso que precisan de altas dosis de insulina con la que marcha de alta. sera preciso que en residencia se evalue la glicemia capilar antes de cada comida (desayuno- comida y cena). endocrinologia dejara analitica y visita de control en 2 semanas de funcion tiroidea. acufeno multifactorial empeorado por su patologia cardiovascular, anemia e hipertiroidismo en el seno de estenosis carotidea significativa. llama la atencion que en el tc craneal presenta sinupatia cronica maxilar derecha con ocupacion completa y remodelacion osea completa, estudio que se completara por orl de manera ambulatoria. en relacion al tinnitus pulsatil, agravado en las ultimas semanas y con dudas de si ademas presenta episodios de palpitaciones en este contexto se acuerda con cardiologia solicitar holter cardiaco que quedara pendiente al alta. en condiciones de estabilidad clinica y de acuerdo con los familiares y la paciente se acuerda alta a residencia en regimen de hado. diagnosticos 1. insuficiencia cardiaca aguda. fep. disfuncion diastolica severa. 2. anemia de etilogia mixta. ferropenica y 2ª a erc. 3. hipertiroidismo por amiodarona tipo 2. 4. insuficiencia respiratoria no hipercapnica. 5. fracaso renal agudo. ercg3b-4. 6. trasplante hepatico. trasplante renal. 7. acufeno de etiologia multifactorial tratamiento y plan al alta debera tomar: - atorvastatina 40mg en la noche - boi-k aspartico 1 comp al dia hasta conrtrol de potasio pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 6 de 8 informe alta hospitalitzacio - carvedilol 6.25mg 1.5 cada 12h. - cellcept 250mg mañana y noche - eliquis 2.5mg mañana y noche - espironolactona 25mg 0.5 comprido al medio dia. - hidroclortiazida 25mg en la mañana - hidroferol 0.266mg 1 vez al mes -lormetazepam 1mg en la noche - losartan 50mg en la mañana - mononitrato de isosorbide 20mg 0.5 comprimido en desayuno, comida y cena - omeprazol 20mg en la mañana - paracetamol 1g solo si precisa - rapamue 1mg en la mañana - torasemida 10mg 1 comprimido en el desayuno y 0.5 en la comida - vesicare 5mg en la noche - prednisona 45mg en la mañana hasta nueva orden - tirodril 5mg 1.5 comprimido en la mañana - septrin 40/800mg 1 comprimido lunes- miercoles y viernes. - insulina novorapid: glucosa - desayuno - comida - cena &lt;100 18 18 8 101-150 20 20 10 151-200 22 22 12 201-250 24 24 14 251-300 26 26 16 301-350 28 28 18 &gt;351 30 30 20 insulina lantus 38-0-0 quedara concretar al alta: - dosis de epo durante el ingreso en hado. despues debera tramitarse por nefrologia de hub al seguir controles en esta unidad en relacion al trasplante renal. alta a residencia con hospitalizacion a domicilio. tipus d'ingres: urgent motiu d'alta: ingres hado metge adjunt: , metge resident: , pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 7 de 8 informe alta hospitalitzacio servei: meduohmb medicina interna data informe: 17.12.2021 pacient cip data naix. 23.01.1941 edat 80 sexe dona nass tel. admissio 15.11.2021 19:34 alta 17.12.2021 11:33 servei meduohmb medicina interna unitat u07uhhbl data i hora d'impressio: 27.12.2021 04:05:30 pagina 8 de 8 informe alta hospitalitzacio\""
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_data['Text'][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "text = train_data['Text'][1]\n",
    "summary = train_data['Summary'][1]\n",
    "\n",
    "text_token = nltk.word_tokenize(text)\n",
    "summary_token = nltk.word_tokenize(summary)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"diagnostic alta codi icd-10 descripcio diagnostic k92.2/1 hemorragia digestiva alta i85.01 varices esofagiques, amb hemorragia dades informe motivo de consulta paciente varon de 64, no amc, que consulta por vomitos en poso de cafe. antecedentes patologicos - trastorno dependencia enolica &gt; 10 ube/ dia - hiperreactividad bronquial - hta. - neumonia comunitaria no complicada hace mas de 20 años. - probable escabiosis/autoeccematizacio diagnosticada en febrero 17 tratada con corticoterapia topica. - insuficiencia renal cronica estadio ii-iiia (fg 40-60). no valorada por nefrologia. - cirrosis hepatica de etiologia enolica child-pugh a. profilaxis primaria para la hemorragia por hipertension portal con carvedilol. (fgs 2020: ve grandes sin signos de riesgo). ultima ecografia abdominal 02/23: muestra porta permeable sin liquido ascitico ni loes hepaticas. en seguimiento por digestivo (dra. martin) no descompensaciones previas. - masa testicular izquierda en estudio por urologia. ecografia testicular 24/05/23: ocupando toda la bolsa escrotal izquierda se aprecia masa heterogenea predominantemente solida con areas de aspecto quistico, con un tamaño de 10 x 8 x 6,5 cm., no vascularizada y que desplaza a teste y epididimo que se muestran vascularizados. l a primera sospecha diagnostica es que se trate de un hematoma en fase de organizacion sin poder descartar otras posibilidades. se aconseja completar el estudio mediante rm escrotal. teste derecho de tamaño, morfologia y ecogenicidad normal, sin lesiones focales, con correcta vascularizacion. epididimo derecho de grosor y ecogenicidad normal. discreto hidrocele derecho. no se aprecian signos de varicocele. cubiertas escrotales sin anomalias. resto de la exploracion ecografica dentro de los limites de la normalidad. + intervenciones quirurgicas en relacion a fistula anal: desbridamiento de absceso perianal en el 2012. fistulotomia en noviembre de 2015. intervenido por recidiva en 2016. ultima cirugia 19/8/2018 (dr. mata- dr. ortiz). fistula posterior a las 5h en talla con cavidad intermedia transesfinteriana alta, sobre area de fibrosis esfinteriana intensa por iq previas. se realiza fistulotomia amplia de todo el trayecto fistuloso y reconstruccion esfinteriana inmediata de todo el aparato esfinteriano fibrotico. controlado en ccee cirugia por. ultima visita en mayo 23: subestenosis fibrotica franqueable facilmente por ecografia endoanal no se visualiza actividad fistulosa , fibrosis importante. + sociofuncional: paciente con las funciones cognitivas preservadas. vive con su mujer e hijo. + tratamiento habitual: carvedilol 6,25mg 0.5/12h , ventolin 100mg, tadalafilo 10mg 1/24h. pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 1 de 5 informe alta hospitalitzacio enfermedad actual consulta por ucias por vomitos en poso de cafe iniciados la tarde del 06/06/23 junto con inestabilidad y perdida de conciencia transitoria. ha estado en tratamiento analgesico con aine la ultima semana por dolor testicular. a su llegada a ucias, paciente con tendencia a la hipotension (media de 105/ 60mmhg) bien tolerada y anemizacion de 5 puntos respecto a control analitico anterior (hb 13g/dl a 8 g/dl). se inicia administracion de bomba de pantoprazol y somatostatina dados los antecedentes. se practica endoscopia digestiva urgente que identifica erosion con fibrina en variz a nivel de union esofago-gastrica colocandose 3 bandas elasticas en punto de sangrado y 2 en variz adyacente. se mantiente perfusion de somatostatina (inicialmente a dosis dobles 6 mg/ 12 h) e ingresa en el servicio digestivo exploracion fisica ta 129/ 66 fc 78x' tª36.8º - ingreso en digestivo: palidez mucocutanea, normohidratado acr sin ruidos sobreañadidis. abd: abdomen globuloso, blando y depresible sin signos de defensa ni semiologia ascitica. dolor a la palpacion hipogastrica. no se palpan masas ni megalias. peristaltismo conservado. ext: no edemas en eeii. teste izquierdo aumentado de tamaño sin signos de flogosis. sn: consciente y orientado. no flapping. pruebas complementarias - analitica urgencias 7/06/23: hb 8,4 g/dl vcm 94 hto 24%, plaquetopenia 44.000 tp 45% urea 28 mg/dl, creatinina 0,8 mg/ dl, sodio 139 mmol/l bb 3,35 mg/dl alt 54 iu/l. glucosa de 153 mg/dl. - analitica (12/06): 4910 leucocitos (fn), hb 8.3 g/ dl, ht 24%, vmc 99, 73.000 plaquetas, tp 91%, glucosa 102, na/ k 140/ 2.8 mmol/l, bil 1.62 mg/ dl, ast/ alt 48/ 45 ui/l, fa/ ggt 93/ 250, proteinas/ alb 55/ 23 g/. - rx de torax ap/l: ict normal, campos pulmonares sin alteraciones. - ecg 07/06 ritmo sinusal sin alteraciones en la repolarizacion - fgs 07/06/23: esofago: exploracion realizada tras iot. mucosa esofagica sin lesiones en tercio superior y medio. en tercio inferior esofagico se identifican 4 cordones de varices esofagicas con paredes azuladas, sin signos de riesgo, 2 desaparecen con la insuflacion y otras 2 que no desaparecen. sobre una de las de tamaño grande, a nivel de la union esofago gastrica existe una erosion con fibrina, a la que se atribuye el origen del sangrado. estomago: lago mucoso con contenido en poso de cafe. tras lavados se visualiza un patron en mosaico con puntos rojos, sin signos de sangrado activo, compatible con gastropatia de la ht portal. incisura sin lesiones. antro sin lesiones. piloro: sin lesiones duodeno: bulbo y segunda porcion duodenales sin lesiones. procedimientos: dados los hallazgos se colocan 5 bandas, la primera sobre el punto erosionado de la variz y 2 bandas mas proximalmente sobre el mismo cordon. se colocan 2 bandas sobre la variz adyacente. complicaciones: ninguna - ecografia abdominal (07/06):higado de ecogenicidad aumentada y tamaño conservado con bordes irregulares y alteracion de la ecoestructura en relacion a hepatopatia cronica. no observo lesiones focales. vena porta de dificil pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 2 de 5 informe alta hospitalitzacio visualizacion (mala ventana + esteatosis), con flujo hepatopetal. via biliar intra y extrahepatica no dilatada. vesicula biliar de dimensiones dentro de la normalidad, alitiasica. pancreas parcialmente visualizado (cabeza, cuerpo) sin lesiones a destacar bazo de morfologia, ecogenicidad y tamaño conservado. riñones con ecoestructura y tamaño conservados. no presenta dilatacion de la via urinaria ni imagenes de litiasis vejiga bien replecionada sin alteraciones a destacar. minima banda de liquido libre en pelvis. - ecografia renovesical (12/03) glandula prostatica volumen aproximado de 28 cc. vejiga urinaria replecionada de paredes lisas. ambos riñones de tamaño y ecoestructura conservada. no dilatacion de la via excretora urinaria ni imagenes de litiasis. liquido ascitico libre abdominal - rmn testicular (12/03): bolsa escrotal derecha: teste derecho de tamaño y morfologia normal (27 x 40 mm), con parenquima homogeneo sin lesiones focales intraparenquimatosas. tras la administracion de contraste intravenoso se observa captaciones anomalas. epididimo de tamaño y morfologia normal. moderado hidrocele derecho, simple, no septado. bolsa escrotal izquierda: cavidades escrotal distendida por presencia de extensa loe de aprox. 70 × 73 × 100 mm de ejes ap, tr y cc respectivamente, ovalada, de contornos bien delimitados, con predominio de hiperseñal en t1 y sin captacion significativa de contraste endovenoso, altamente sugestiva de hematoma organizado, observando areas en su interior geograficas con restriccion a la difusion que podrian sugerir coagulos. el teste izquierdo se observa con dificultad y parece estar disminuido de tamaño (10 × 27 mm) aparentemente comprimido y desplazado en sentido posterior, con irregularidad en su polo posterior, laceracion? a valorar antecedente traumatico. - paracentesis diagnostica (12/06) blanca -hemocultivos: negativos hasta el alta -sedimento orina 1-3 leucos/ campo -pcr covid19 (13/06) negativo orientacion diagnostica 1.- hemorragia digestiva alta por varices esofagicas. ligadura con bandas elasticas. cirrosis hepatica alcoholica child b. meld 17 puntos paciente con antecedente de cirrosis hepatica alcoholica que ingresa por vomitos en posos de cafe sin inestabilidad hemodinamica asociada. se realiza gastroscopia urgente en la que se observan varices esofagicas grandes y erosion en una de ellas, se procede a colocacion de bandas elasticas. se inicia tratamiento medico con somatostatina a dosis doble inicialmente y posteriormente a dosis habituales durante 5 dias en total y se inicia tratamiento con carvedilol 6.25mg: 1-0-1.5 sin incidencias. durante el ingreso se inicio tratamiento antibiotico profilactico con ceftriaxona 1gr/dia iv , profilaxis para encefalopatia hepatica con lactulosa oral y profilaxis de sd de abstinencia. se realizo ecografia abdominal sin loes hepaticas ni trombosis del eje esplenoportal. dada la estabilidad hemodinamica, adecuada tolerancia oral y ausencia de melenas o vomitos en posos de cafe se decide alta hospitalaria. 2.- anemia aguda secundaria a 1 hb 8,4g/dl inicial con descenso hasta hb 6,4 g/ dl requiriendo 2 concentrados de hematies. al alta hb 8.3 g/ dl 3.- ascitis grado i y edemas pretibiales. cirrosis hepatica enolica child pugh b7 pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 3 de 5 informe alta hospitalitzacio en este ingreso desarrolla liquido libre tipo i (paracentesis blanca) y edemas en eeii inciandose espironolactona 50 mg/ 24 h. 4.- trastorno dependencia alcoholica enolismo activo hasta el ingreso. durante el ingreso ha realizado deshabituacion farmacologica con clometiazol. no ha presentado sintomas de abstinencia. se le ofrece vinculacion con centro de deshabituacion / ccee psiquiatria para mantener abstinencia, pero el paciente lo rechaza por el momento. 5.- rao resuelta durante el ingreso. valorado por urologia quienes recomiendan inicio de tamsulosina 0.4mg/dia 6.- febricula sin foco. ulltimos dias ingresado presenta una febricula sin foco y con buen estado clinico. hc y uc negativos. pcr covid 19 negativo y paracentesis blanca. sin nuevos episodios de febricula 24 horas previas al alta. 7.- masa testicular izquierda a estudio se completa estudio durante el ingreso mediante rmn obteniendo imagenes compatibles con hematoma organizado. seguira controles de forma ambulatoria por urologia recomendaciones y tratamiento al alta - abstinencia absoluta de alcohol - dieta baja en sal - control de peso, tensiones arteriales y frecuencias cardiacas - acfol 1c/ dia durante un mes - ferro-sanol 1c/ dia (las deposiciones seran de color negruzcas) durante 1 mes - hidroxil b1-b6-b12 1c/ 12 h durante un mes - carvedilol 6,25 mg 1-0-1,5 - espironolactona 100 mg 1-0-0 - furosemida 40 mg 1-0-0 - lactulosa: 1 sobre al dia. suspender si diarreas - tamsulosina 0,4mg, 1-0-0 control - control y seguimiento en consulta ch intensivo (dra martin) previa analitica - control y seguimiento en urologia - se programa 2º sesion de ligadura de varices esofagicas tipus d'ingres: urgent motiu d'alta: alt.med.domicil metge adjunt: , pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 4 de 5 informe alta hospitalitzacio data informe: 15.06.2023 pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 5 de 5 informe alta hospitalitzacio\""
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['diagnostic',\n",
       " 'alta',\n",
       " 'codi',\n",
       " 'icd-10',\n",
       " 'descripcio',\n",
       " 'diagnostic',\n",
       " 'k92.2/1',\n",
       " 'hemorragia',\n",
       " 'digestiva',\n",
       " 'alta',\n",
       " 'i85.01',\n",
       " 'varices',\n",
       " 'esofagiques',\n",
       " ',',\n",
       " 'amb',\n",
       " 'hemorragia',\n",
       " 'dades',\n",
       " 'informe',\n",
       " 'motivo',\n",
       " 'de',\n",
       " 'consulta',\n",
       " 'paciente',\n",
       " 'varon',\n",
       " 'de',\n",
       " '64',\n",
       " ',',\n",
       " 'no',\n",
       " 'amc',\n",
       " ',',\n",
       " 'que',\n",
       " 'consulta',\n",
       " 'por',\n",
       " 'vomitos',\n",
       " 'en',\n",
       " 'poso',\n",
       " 'de',\n",
       " 'cafe',\n",
       " '.',\n",
       " 'antecedentes',\n",
       " 'patologicos',\n",
       " '-',\n",
       " 'trastorno',\n",
       " 'dependencia',\n",
       " 'enolica',\n",
       " '&',\n",
       " 'gt',\n",
       " ';',\n",
       " '10',\n",
       " 'ube/',\n",
       " 'dia',\n",
       " '-',\n",
       " 'hiperreactividad',\n",
       " 'bronquial',\n",
       " '-',\n",
       " 'hta',\n",
       " '.',\n",
       " '-',\n",
       " 'neumonia',\n",
       " 'comunitaria',\n",
       " 'no',\n",
       " 'complicada',\n",
       " 'hace',\n",
       " 'mas',\n",
       " 'de',\n",
       " '20',\n",
       " 'años',\n",
       " '.',\n",
       " '-',\n",
       " 'probable',\n",
       " 'escabiosis/autoeccematizacio',\n",
       " 'diagnosticada',\n",
       " 'en',\n",
       " 'febrero',\n",
       " '17',\n",
       " 'tratada',\n",
       " 'con',\n",
       " 'corticoterapia',\n",
       " 'topica',\n",
       " '.',\n",
       " '-',\n",
       " 'insuficiencia',\n",
       " 'renal',\n",
       " 'cronica',\n",
       " 'estadio',\n",
       " 'ii-iiia',\n",
       " '(',\n",
       " 'fg',\n",
       " '40-60',\n",
       " ')',\n",
       " '.',\n",
       " 'no',\n",
       " 'valorada',\n",
       " 'por',\n",
       " 'nefrologia',\n",
       " '.',\n",
       " '-',\n",
       " 'cirrosis',\n",
       " 'hepatica',\n",
       " 'de',\n",
       " 'etiologia',\n",
       " 'enolica',\n",
       " 'child-pugh',\n",
       " 'a.',\n",
       " 'profilaxis',\n",
       " 'primaria',\n",
       " 'para',\n",
       " 'la',\n",
       " 'hemorragia',\n",
       " 'por',\n",
       " 'hipertension',\n",
       " 'portal',\n",
       " 'con',\n",
       " 'carvedilol',\n",
       " '.',\n",
       " '(',\n",
       " 'fgs',\n",
       " '2020',\n",
       " ':',\n",
       " 've',\n",
       " 'grandes',\n",
       " 'sin',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'riesgo',\n",
       " ')',\n",
       " '.',\n",
       " 'ultima',\n",
       " 'ecografia',\n",
       " 'abdominal',\n",
       " '02/23',\n",
       " ':',\n",
       " 'muestra',\n",
       " 'porta',\n",
       " 'permeable',\n",
       " 'sin',\n",
       " 'liquido',\n",
       " 'ascitico',\n",
       " 'ni',\n",
       " 'loes',\n",
       " 'hepaticas',\n",
       " '.',\n",
       " 'en',\n",
       " 'seguimiento',\n",
       " 'por',\n",
       " 'digestivo',\n",
       " '(',\n",
       " 'dra',\n",
       " '.',\n",
       " 'martin',\n",
       " ')',\n",
       " 'no',\n",
       " 'descompensaciones',\n",
       " 'previas',\n",
       " '.',\n",
       " '-',\n",
       " 'masa',\n",
       " 'testicular',\n",
       " 'izquierda',\n",
       " 'en',\n",
       " 'estudio',\n",
       " 'por',\n",
       " 'urologia',\n",
       " '.',\n",
       " 'ecografia',\n",
       " 'testicular',\n",
       " '24/05/23',\n",
       " ':',\n",
       " 'ocupando',\n",
       " 'toda',\n",
       " 'la',\n",
       " 'bolsa',\n",
       " 'escrotal',\n",
       " 'izquierda',\n",
       " 'se',\n",
       " 'aprecia',\n",
       " 'masa',\n",
       " 'heterogenea',\n",
       " 'predominantemente',\n",
       " 'solida',\n",
       " 'con',\n",
       " 'areas',\n",
       " 'de',\n",
       " 'aspecto',\n",
       " 'quistico',\n",
       " ',',\n",
       " 'con',\n",
       " 'un',\n",
       " 'tamaño',\n",
       " 'de',\n",
       " '10',\n",
       " 'x',\n",
       " '8',\n",
       " 'x',\n",
       " '6,5',\n",
       " 'cm.',\n",
       " ',',\n",
       " 'no',\n",
       " 'vascularizada',\n",
       " 'y',\n",
       " 'que',\n",
       " 'desplaza',\n",
       " 'a',\n",
       " 'teste',\n",
       " 'y',\n",
       " 'epididimo',\n",
       " 'que',\n",
       " 'se',\n",
       " 'muestran',\n",
       " 'vascularizados',\n",
       " '.',\n",
       " 'l',\n",
       " 'a',\n",
       " 'primera',\n",
       " 'sospecha',\n",
       " 'diagnostica',\n",
       " 'es',\n",
       " 'que',\n",
       " 'se',\n",
       " 'trate',\n",
       " 'de',\n",
       " 'un',\n",
       " 'hematoma',\n",
       " 'en',\n",
       " 'fase',\n",
       " 'de',\n",
       " 'organizacion',\n",
       " 'sin',\n",
       " 'poder',\n",
       " 'descartar',\n",
       " 'otras',\n",
       " 'posibilidades',\n",
       " '.',\n",
       " 'se',\n",
       " 'aconseja',\n",
       " 'completar',\n",
       " 'el',\n",
       " 'estudio',\n",
       " 'mediante',\n",
       " 'rm',\n",
       " 'escrotal',\n",
       " '.',\n",
       " 'teste',\n",
       " 'derecho',\n",
       " 'de',\n",
       " 'tamaño',\n",
       " ',',\n",
       " 'morfologia',\n",
       " 'y',\n",
       " 'ecogenicidad',\n",
       " 'normal',\n",
       " ',',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " 'focales',\n",
       " ',',\n",
       " 'con',\n",
       " 'correcta',\n",
       " 'vascularizacion',\n",
       " '.',\n",
       " 'epididimo',\n",
       " 'derecho',\n",
       " 'de',\n",
       " 'grosor',\n",
       " 'y',\n",
       " 'ecogenicidad',\n",
       " 'normal',\n",
       " '.',\n",
       " 'discreto',\n",
       " 'hidrocele',\n",
       " 'derecho',\n",
       " '.',\n",
       " 'no',\n",
       " 'se',\n",
       " 'aprecian',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'varicocele',\n",
       " '.',\n",
       " 'cubiertas',\n",
       " 'escrotales',\n",
       " 'sin',\n",
       " 'anomalias',\n",
       " '.',\n",
       " 'resto',\n",
       " 'de',\n",
       " 'la',\n",
       " 'exploracion',\n",
       " 'ecografica',\n",
       " 'dentro',\n",
       " 'de',\n",
       " 'los',\n",
       " 'limites',\n",
       " 'de',\n",
       " 'la',\n",
       " 'normalidad',\n",
       " '.',\n",
       " '+',\n",
       " 'intervenciones',\n",
       " 'quirurgicas',\n",
       " 'en',\n",
       " 'relacion',\n",
       " 'a',\n",
       " 'fistula',\n",
       " 'anal',\n",
       " ':',\n",
       " 'desbridamiento',\n",
       " 'de',\n",
       " 'absceso',\n",
       " 'perianal',\n",
       " 'en',\n",
       " 'el',\n",
       " '2012.',\n",
       " 'fistulotomia',\n",
       " 'en',\n",
       " 'noviembre',\n",
       " 'de',\n",
       " '2015.',\n",
       " 'intervenido',\n",
       " 'por',\n",
       " 'recidiva',\n",
       " 'en',\n",
       " '2016.',\n",
       " 'ultima',\n",
       " 'cirugia',\n",
       " '19/8/2018',\n",
       " '(',\n",
       " 'dr.',\n",
       " 'mata-',\n",
       " 'dr.',\n",
       " 'ortiz',\n",
       " ')',\n",
       " '.',\n",
       " 'fistula',\n",
       " 'posterior',\n",
       " 'a',\n",
       " 'las',\n",
       " '5h',\n",
       " 'en',\n",
       " 'talla',\n",
       " 'con',\n",
       " 'cavidad',\n",
       " 'intermedia',\n",
       " 'transesfinteriana',\n",
       " 'alta',\n",
       " ',',\n",
       " 'sobre',\n",
       " 'area',\n",
       " 'de',\n",
       " 'fibrosis',\n",
       " 'esfinteriana',\n",
       " 'intensa',\n",
       " 'por',\n",
       " 'iq',\n",
       " 'previas',\n",
       " '.',\n",
       " 'se',\n",
       " 'realiza',\n",
       " 'fistulotomia',\n",
       " 'amplia',\n",
       " 'de',\n",
       " 'todo',\n",
       " 'el',\n",
       " 'trayecto',\n",
       " 'fistuloso',\n",
       " 'y',\n",
       " 'reconstruccion',\n",
       " 'esfinteriana',\n",
       " 'inmediata',\n",
       " 'de',\n",
       " 'todo',\n",
       " 'el',\n",
       " 'aparato',\n",
       " 'esfinteriano',\n",
       " 'fibrotico',\n",
       " '.',\n",
       " 'controlado',\n",
       " 'en',\n",
       " 'ccee',\n",
       " 'cirugia',\n",
       " 'por',\n",
       " '.',\n",
       " 'ultima',\n",
       " 'visita',\n",
       " 'en',\n",
       " 'mayo',\n",
       " '23',\n",
       " ':',\n",
       " 'subestenosis',\n",
       " 'fibrotica',\n",
       " 'franqueable',\n",
       " 'facilmente',\n",
       " 'por',\n",
       " 'ecografia',\n",
       " 'endoanal',\n",
       " 'no',\n",
       " 'se',\n",
       " 'visualiza',\n",
       " 'actividad',\n",
       " 'fistulosa',\n",
       " ',',\n",
       " 'fibrosis',\n",
       " 'importante',\n",
       " '.',\n",
       " '+',\n",
       " 'sociofuncional',\n",
       " ':',\n",
       " 'paciente',\n",
       " 'con',\n",
       " 'las',\n",
       " 'funciones',\n",
       " 'cognitivas',\n",
       " 'preservadas',\n",
       " '.',\n",
       " 'vive',\n",
       " 'con',\n",
       " 'su',\n",
       " 'mujer',\n",
       " 'e',\n",
       " 'hijo',\n",
       " '.',\n",
       " '+',\n",
       " 'tratamiento',\n",
       " 'habitual',\n",
       " ':',\n",
       " 'carvedilol',\n",
       " '6,25mg',\n",
       " '0.5/12h',\n",
       " ',',\n",
       " 'ventolin',\n",
       " '100mg',\n",
       " ',',\n",
       " 'tadalafilo',\n",
       " '10mg',\n",
       " '1/24h',\n",
       " '.',\n",
       " 'pacient',\n",
       " 'cip',\n",
       " 'data',\n",
       " 'naix',\n",
       " '.',\n",
       " '15.08.1958',\n",
       " 'edat',\n",
       " '64',\n",
       " 'sexe',\n",
       " 'home',\n",
       " 'nass',\n",
       " 'adreça',\n",
       " 'cp',\n",
       " 'poblacio',\n",
       " 'tel',\n",
       " '.',\n",
       " 'admissio',\n",
       " '07.06.2023',\n",
       " '11:52',\n",
       " 'alta',\n",
       " '15.06.2023',\n",
       " '12:29',\n",
       " 'data',\n",
       " 'i',\n",
       " 'hora',\n",
       " \"d'impressio\",\n",
       " ':',\n",
       " '17.06.2023',\n",
       " '05:01:07',\n",
       " 'pagina',\n",
       " '1',\n",
       " 'de',\n",
       " '5',\n",
       " 'informe',\n",
       " 'alta',\n",
       " 'hospitalitzacio',\n",
       " 'enfermedad',\n",
       " 'actual',\n",
       " 'consulta',\n",
       " 'por',\n",
       " 'ucias',\n",
       " 'por',\n",
       " 'vomitos',\n",
       " 'en',\n",
       " 'poso',\n",
       " 'de',\n",
       " 'cafe',\n",
       " 'iniciados',\n",
       " 'la',\n",
       " 'tarde',\n",
       " 'del',\n",
       " '06/06/23',\n",
       " 'junto',\n",
       " 'con',\n",
       " 'inestabilidad',\n",
       " 'y',\n",
       " 'perdida',\n",
       " 'de',\n",
       " 'conciencia',\n",
       " 'transitoria',\n",
       " '.',\n",
       " 'ha',\n",
       " 'estado',\n",
       " 'en',\n",
       " 'tratamiento',\n",
       " 'analgesico',\n",
       " 'con',\n",
       " 'aine',\n",
       " 'la',\n",
       " 'ultima',\n",
       " 'semana',\n",
       " 'por',\n",
       " 'dolor',\n",
       " 'testicular',\n",
       " '.',\n",
       " 'a',\n",
       " 'su',\n",
       " 'llegada',\n",
       " 'a',\n",
       " 'ucias',\n",
       " ',',\n",
       " 'paciente',\n",
       " 'con',\n",
       " 'tendencia',\n",
       " 'a',\n",
       " 'la',\n",
       " 'hipotension',\n",
       " '(',\n",
       " 'media',\n",
       " 'de',\n",
       " '105/',\n",
       " '60mmhg',\n",
       " ')',\n",
       " 'bien',\n",
       " 'tolerada',\n",
       " 'y',\n",
       " 'anemizacion',\n",
       " 'de',\n",
       " '5',\n",
       " 'puntos',\n",
       " 'respecto',\n",
       " 'a',\n",
       " 'control',\n",
       " 'analitico',\n",
       " 'anterior',\n",
       " '(',\n",
       " 'hb',\n",
       " '13g/dl',\n",
       " 'a',\n",
       " '8',\n",
       " 'g/dl',\n",
       " ')',\n",
       " '.',\n",
       " 'se',\n",
       " 'inicia',\n",
       " 'administracion',\n",
       " 'de',\n",
       " 'bomba',\n",
       " 'de',\n",
       " 'pantoprazol',\n",
       " 'y',\n",
       " 'somatostatina',\n",
       " 'dados',\n",
       " 'los',\n",
       " 'antecedentes',\n",
       " '.',\n",
       " 'se',\n",
       " 'practica',\n",
       " 'endoscopia',\n",
       " 'digestiva',\n",
       " 'urgente',\n",
       " 'que',\n",
       " 'identifica',\n",
       " 'erosion',\n",
       " 'con',\n",
       " 'fibrina',\n",
       " 'en',\n",
       " 'variz',\n",
       " 'a',\n",
       " 'nivel',\n",
       " 'de',\n",
       " 'union',\n",
       " 'esofago-gastrica',\n",
       " 'colocandose',\n",
       " '3',\n",
       " 'bandas',\n",
       " 'elasticas',\n",
       " 'en',\n",
       " 'punto',\n",
       " 'de',\n",
       " 'sangrado',\n",
       " 'y',\n",
       " '2',\n",
       " 'en',\n",
       " 'variz',\n",
       " 'adyacente',\n",
       " '.',\n",
       " 'se',\n",
       " 'mantiente',\n",
       " 'perfusion',\n",
       " 'de',\n",
       " 'somatostatina',\n",
       " '(',\n",
       " 'inicialmente',\n",
       " 'a',\n",
       " 'dosis',\n",
       " 'dobles',\n",
       " '6',\n",
       " 'mg/',\n",
       " '12',\n",
       " 'h',\n",
       " ')',\n",
       " 'e',\n",
       " 'ingresa',\n",
       " 'en',\n",
       " 'el',\n",
       " 'servicio',\n",
       " 'digestivo',\n",
       " 'exploracion',\n",
       " 'fisica',\n",
       " 'ta',\n",
       " '129/',\n",
       " '66',\n",
       " 'fc',\n",
       " '78x',\n",
       " \"'\",\n",
       " 'tª36.8º',\n",
       " '-',\n",
       " 'ingreso',\n",
       " 'en',\n",
       " 'digestivo',\n",
       " ':',\n",
       " 'palidez',\n",
       " 'mucocutanea',\n",
       " ',',\n",
       " 'normohidratado',\n",
       " 'acr',\n",
       " 'sin',\n",
       " 'ruidos',\n",
       " 'sobreañadidis',\n",
       " '.',\n",
       " 'abd',\n",
       " ':',\n",
       " 'abdomen',\n",
       " 'globuloso',\n",
       " ',',\n",
       " 'blando',\n",
       " 'y',\n",
       " 'depresible',\n",
       " 'sin',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'defensa',\n",
       " 'ni',\n",
       " 'semiologia',\n",
       " 'ascitica',\n",
       " '.',\n",
       " 'dolor',\n",
       " 'a',\n",
       " 'la',\n",
       " 'palpacion',\n",
       " 'hipogastrica',\n",
       " '.',\n",
       " 'no',\n",
       " 'se',\n",
       " 'palpan',\n",
       " 'masas',\n",
       " 'ni',\n",
       " 'megalias',\n",
       " '.',\n",
       " 'peristaltismo',\n",
       " 'conservado',\n",
       " '.',\n",
       " 'ext',\n",
       " ':',\n",
       " 'no',\n",
       " 'edemas',\n",
       " 'en',\n",
       " 'eeii',\n",
       " '.',\n",
       " 'teste',\n",
       " 'izquierdo',\n",
       " 'aumentado',\n",
       " 'de',\n",
       " 'tamaño',\n",
       " 'sin',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'flogosis',\n",
       " '.',\n",
       " 'sn',\n",
       " ':',\n",
       " 'consciente',\n",
       " 'y',\n",
       " 'orientado',\n",
       " '.',\n",
       " 'no',\n",
       " 'flapping',\n",
       " '.',\n",
       " 'pruebas',\n",
       " 'complementarias',\n",
       " '-',\n",
       " 'analitica',\n",
       " 'urgencias',\n",
       " '7/06/23',\n",
       " ':',\n",
       " 'hb',\n",
       " '8,4',\n",
       " 'g/dl',\n",
       " 'vcm',\n",
       " '94',\n",
       " 'hto',\n",
       " '24',\n",
       " '%',\n",
       " ',',\n",
       " 'plaquetopenia',\n",
       " '44.000',\n",
       " 'tp',\n",
       " '45',\n",
       " '%',\n",
       " 'urea',\n",
       " '28',\n",
       " 'mg/dl',\n",
       " ',',\n",
       " 'creatinina',\n",
       " '0,8',\n",
       " 'mg/',\n",
       " 'dl',\n",
       " ',',\n",
       " 'sodio',\n",
       " '139',\n",
       " 'mmol/l',\n",
       " 'bb',\n",
       " '3,35',\n",
       " 'mg/dl',\n",
       " 'alt',\n",
       " '54',\n",
       " 'iu/l',\n",
       " '.',\n",
       " 'glucosa',\n",
       " 'de',\n",
       " '153',\n",
       " 'mg/dl',\n",
       " '.',\n",
       " '-',\n",
       " 'analitica',\n",
       " '(',\n",
       " '12/06',\n",
       " ')',\n",
       " ':',\n",
       " '4910',\n",
       " 'leucocitos',\n",
       " '(',\n",
       " 'fn',\n",
       " ')',\n",
       " ',',\n",
       " 'hb',\n",
       " '8.3',\n",
       " 'g/',\n",
       " 'dl',\n",
       " ',',\n",
       " 'ht',\n",
       " '24',\n",
       " '%',\n",
       " ',',\n",
       " 'vmc',\n",
       " '99',\n",
       " ',',\n",
       " '73.000',\n",
       " 'plaquetas',\n",
       " ',',\n",
       " 'tp',\n",
       " '91',\n",
       " '%',\n",
       " ',',\n",
       " 'glucosa',\n",
       " '102',\n",
       " ',',\n",
       " 'na/',\n",
       " 'k',\n",
       " '140/',\n",
       " '2.8',\n",
       " 'mmol/l',\n",
       " ',',\n",
       " 'bil',\n",
       " '1.62',\n",
       " 'mg/',\n",
       " 'dl',\n",
       " ',',\n",
       " 'ast/',\n",
       " 'alt',\n",
       " '48/',\n",
       " '45',\n",
       " 'ui/l',\n",
       " ',',\n",
       " 'fa/',\n",
       " 'ggt',\n",
       " '93/',\n",
       " '250',\n",
       " ',',\n",
       " 'proteinas/',\n",
       " 'alb',\n",
       " '55/',\n",
       " '23',\n",
       " 'g/',\n",
       " '.',\n",
       " '-',\n",
       " 'rx',\n",
       " 'de',\n",
       " 'torax',\n",
       " 'ap/l',\n",
       " ':',\n",
       " 'ict',\n",
       " 'normal',\n",
       " ',',\n",
       " 'campos',\n",
       " 'pulmonares',\n",
       " 'sin',\n",
       " 'alteraciones',\n",
       " '.',\n",
       " '-',\n",
       " 'ecg',\n",
       " '07/06',\n",
       " 'ritmo',\n",
       " 'sinusal',\n",
       " 'sin',\n",
       " 'alteraciones',\n",
       " 'en',\n",
       " 'la',\n",
       " 'repolarizacion',\n",
       " '-',\n",
       " 'fgs',\n",
       " '07/06/23',\n",
       " ':',\n",
       " 'esofago',\n",
       " ':',\n",
       " 'exploracion',\n",
       " 'realizada',\n",
       " 'tras',\n",
       " 'iot',\n",
       " '.',\n",
       " 'mucosa',\n",
       " 'esofagica',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " 'en',\n",
       " 'tercio',\n",
       " 'superior',\n",
       " 'y',\n",
       " 'medio',\n",
       " '.',\n",
       " 'en',\n",
       " 'tercio',\n",
       " 'inferior',\n",
       " 'esofagico',\n",
       " 'se',\n",
       " 'identifican',\n",
       " '4',\n",
       " 'cordones',\n",
       " 'de',\n",
       " 'varices',\n",
       " 'esofagicas',\n",
       " 'con',\n",
       " 'paredes',\n",
       " 'azuladas',\n",
       " ',',\n",
       " 'sin',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'riesgo',\n",
       " ',',\n",
       " '2',\n",
       " 'desaparecen',\n",
       " 'con',\n",
       " 'la',\n",
       " 'insuflacion',\n",
       " 'y',\n",
       " 'otras',\n",
       " '2',\n",
       " 'que',\n",
       " 'no',\n",
       " 'desaparecen',\n",
       " '.',\n",
       " 'sobre',\n",
       " 'una',\n",
       " 'de',\n",
       " 'las',\n",
       " 'de',\n",
       " 'tamaño',\n",
       " 'grande',\n",
       " ',',\n",
       " 'a',\n",
       " 'nivel',\n",
       " 'de',\n",
       " 'la',\n",
       " 'union',\n",
       " 'esofago',\n",
       " 'gastrica',\n",
       " 'existe',\n",
       " 'una',\n",
       " 'erosion',\n",
       " 'con',\n",
       " 'fibrina',\n",
       " ',',\n",
       " 'a',\n",
       " 'la',\n",
       " 'que',\n",
       " 'se',\n",
       " 'atribuye',\n",
       " 'el',\n",
       " 'origen',\n",
       " 'del',\n",
       " 'sangrado',\n",
       " '.',\n",
       " 'estomago',\n",
       " ':',\n",
       " 'lago',\n",
       " 'mucoso',\n",
       " 'con',\n",
       " 'contenido',\n",
       " 'en',\n",
       " 'poso',\n",
       " 'de',\n",
       " 'cafe',\n",
       " '.',\n",
       " 'tras',\n",
       " 'lavados',\n",
       " 'se',\n",
       " 'visualiza',\n",
       " 'un',\n",
       " 'patron',\n",
       " 'en',\n",
       " 'mosaico',\n",
       " 'con',\n",
       " 'puntos',\n",
       " 'rojos',\n",
       " ',',\n",
       " 'sin',\n",
       " 'signos',\n",
       " 'de',\n",
       " 'sangrado',\n",
       " 'activo',\n",
       " ',',\n",
       " 'compatible',\n",
       " 'con',\n",
       " 'gastropatia',\n",
       " 'de',\n",
       " 'la',\n",
       " 'ht',\n",
       " 'portal',\n",
       " '.',\n",
       " 'incisura',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " '.',\n",
       " 'antro',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " '.',\n",
       " 'piloro',\n",
       " ':',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " 'duodeno',\n",
       " ':',\n",
       " 'bulbo',\n",
       " 'y',\n",
       " 'segunda',\n",
       " 'porcion',\n",
       " 'duodenales',\n",
       " 'sin',\n",
       " 'lesiones',\n",
       " '.',\n",
       " 'procedimientos',\n",
       " ':',\n",
       " 'dados',\n",
       " 'los',\n",
       " 'hallazgos',\n",
       " 'se',\n",
       " 'colocan',\n",
       " '5',\n",
       " 'bandas',\n",
       " ',',\n",
       " 'la',\n",
       " 'primera',\n",
       " 'sobre',\n",
       " 'el',\n",
       " 'punto',\n",
       " 'erosionado',\n",
       " 'de',\n",
       " 'la',\n",
       " 'variz',\n",
       " 'y',\n",
       " '2',\n",
       " 'bandas',\n",
       " 'mas',\n",
       " 'proximalmente',\n",
       " 'sobre',\n",
       " 'el',\n",
       " 'mismo',\n",
       " 'cordon',\n",
       " '.',\n",
       " 'se',\n",
       " 'colocan',\n",
       " '2',\n",
       " ...]"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text_token"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\"diagnostic alta codi icd-10 descripcio diagnostic k92.2/1 hemorragia digestiva alta i85.01 varices esofagiques, amb hemorragia dades informe motivo de consulta paciente varon de 64, no amc, que consulta por vomitos en poso de cafe. antecedentes patologicos - trastorno dependencia enolica &gt; 10 ube/ dia - hiperreactividad bronquial - hta. - neumonia comunitaria no complicada hace mas de 20 años. - probable escabiosis/autoeccematizacio diagnosticada en febrero 17 tratada con corticoterapia topica. - insuficiencia renal cronica estadio ii-iiia (fg 40-60). no valorada por nefrologia. - cirrosis hepatica de etiologia enolica child-pugh a. profilaxis primaria para la hemorragia por hipertension portal con carvedilol. (fgs 2020: ve grandes sin signos de riesgo). ultima ecografia abdominal 02/23: muestra porta permeable sin liquido ascitico ni loes hepaticas. en seguimiento por digestivo (dra. martin) no descompensaciones previas. - masa testicular izquierda en estudio por urologia. ecografia testicular 24/05/23: ocupando toda la bolsa escrotal izquierda se aprecia masa heterogenea predominantemente solida con areas de aspecto quistico, con un tamaño de 10 x 8 x 6,5 cm., no vascularizada y que desplaza a teste y epididimo que se muestran vascularizados. l a primera sospecha diagnostica es que se trate de un hematoma en fase de organizacion sin poder descartar otras posibilidades. se aconseja completar el estudio mediante rm escrotal. teste derecho de tamaño, morfologia y ecogenicidad normal, sin lesiones focales, con correcta vascularizacion. epididimo derecho de grosor y ecogenicidad normal. discreto hidrocele derecho. no se aprecian signos de varicocele. cubiertas escrotales sin anomalias. resto de la exploracion ecografica dentro de los limites de la normalidad. + intervenciones quirurgicas en relacion a fistula anal: desbridamiento de absceso perianal en el 2012. fistulotomia en noviembre de 2015. intervenido por recidiva en 2016. ultima cirugia 19/8/2018 (dr. mata- dr. ortiz). fistula posterior a las 5h en talla con cavidad intermedia transesfinteriana alta, sobre area de fibrosis esfinteriana intensa por iq previas. se realiza fistulotomia amplia de todo el trayecto fistuloso y reconstruccion esfinteriana inmediata de todo el aparato esfinteriano fibrotico. controlado en ccee cirugia por. ultima visita en mayo 23: subestenosis fibrotica franqueable facilmente por ecografia endoanal no se visualiza actividad fistulosa , fibrosis importante. + sociofuncional: paciente con las funciones cognitivas preservadas. vive con su mujer e hijo. + tratamiento habitual: carvedilol 6,25mg 0.5/12h , ventolin 100mg, tadalafilo 10mg 1/24h. pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 1 de 5 informe alta hospitalitzacio enfermedad actual consulta por ucias por vomitos en poso de cafe iniciados la tarde del 06/06/23 junto con inestabilidad y perdida de conciencia transitoria. ha estado en tratamiento analgesico con aine la ultima semana por dolor testicular. a su llegada a ucias, paciente con tendencia a la hipotension (media de 105/ 60mmhg) bien tolerada y anemizacion de 5 puntos respecto a control analitico anterior (hb 13g/dl a 8 g/dl). se inicia administracion de bomba de pantoprazol y somatostatina dados los antecedentes. se practica endoscopia digestiva urgente que identifica erosion con fibrina en variz a nivel de union esofago-gastrica colocandose 3 bandas elasticas en punto de sangrado y 2 en variz adyacente. se mantiente perfusion de somatostatina (inicialmente a dosis dobles 6 mg/ 12 h) e ingresa en el servicio digestivo exploracion fisica ta 129/ 66 fc 78x' tª36.8º - ingreso en digestivo: palidez mucocutanea, normohidratado acr sin ruidos sobreañadidis. abd: abdomen globuloso, blando y depresible sin signos de defensa ni semiologia ascitica. dolor a la palpacion hipogastrica. no se palpan masas ni megalias. peristaltismo conservado. ext: no edemas en eeii. teste izquierdo aumentado de tamaño sin signos de flogosis. sn: consciente y orientado. no flapping. pruebas complementarias - analitica urgencias 7/06/23: hb 8,4 g/dl vcm 94 hto 24%, plaquetopenia 44.000 tp 45% urea 28 mg/dl, creatinina 0,8 mg/ dl, sodio 139 mmol/l bb 3,35 mg/dl alt 54 iu/l. glucosa de 153 mg/dl. - analitica (12/06): 4910 leucocitos (fn), hb 8.3 g/ dl, ht 24%, vmc 99, 73.000 plaquetas, tp 91%, glucosa 102, na/ k 140/ 2.8 mmol/l, bil 1.62 mg/ dl, ast/ alt 48/ 45 ui/l, fa/ ggt 93/ 250, proteinas/ alb 55/ 23 g/. - rx de torax ap/l: ict normal, campos pulmonares sin alteraciones. - ecg 07/06 ritmo sinusal sin alteraciones en la repolarizacion - fgs 07/06/23: esofago: exploracion realizada tras iot. mucosa esofagica sin lesiones en tercio superior y medio. en tercio inferior esofagico se identifican 4 cordones de varices esofagicas con paredes azuladas, sin signos de riesgo, 2 desaparecen con la insuflacion y otras 2 que no desaparecen. sobre una de las de tamaño grande, a nivel de la union esofago gastrica existe una erosion con fibrina, a la que se atribuye el origen del sangrado. estomago: lago mucoso con contenido en poso de cafe. tras lavados se visualiza un patron en mosaico con puntos rojos, sin signos de sangrado activo, compatible con gastropatia de la ht portal. incisura sin lesiones. antro sin lesiones. piloro: sin lesiones duodeno: bulbo y segunda porcion duodenales sin lesiones. procedimientos: dados los hallazgos se colocan 5 bandas, la primera sobre el punto erosionado de la variz y 2 bandas mas proximalmente sobre el mismo cordon. se colocan 2 bandas sobre la variz adyacente. complicaciones: ninguna - ecografia abdominal (07/06):higado de ecogenicidad aumentada y tamaño conservado con bordes irregulares y alteracion de la ecoestructura en relacion a hepatopatia cronica. no observo lesiones focales. vena porta de dificil pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 2 de 5 informe alta hospitalitzacio visualizacion (mala ventana + esteatosis), con flujo hepatopetal. via biliar intra y extrahepatica no dilatada. vesicula biliar de dimensiones dentro de la normalidad, alitiasica. pancreas parcialmente visualizado (cabeza, cuerpo) sin lesiones a destacar bazo de morfologia, ecogenicidad y tamaño conservado. riñones con ecoestructura y tamaño conservados. no presenta dilatacion de la via urinaria ni imagenes de litiasis vejiga bien replecionada sin alteraciones a destacar. minima banda de liquido libre en pelvis. - ecografia renovesical (12/03) glandula prostatica volumen aproximado de 28 cc. vejiga urinaria replecionada de paredes lisas. ambos riñones de tamaño y ecoestructura conservada. no dilatacion de la via excretora urinaria ni imagenes de litiasis. liquido ascitico libre abdominal - rmn testicular (12/03): bolsa escrotal derecha: teste derecho de tamaño y morfologia normal (27 x 40 mm), con parenquima homogeneo sin lesiones focales intraparenquimatosas. tras la administracion de contraste intravenoso se observa captaciones anomalas. epididimo de tamaño y morfologia normal. moderado hidrocele derecho, simple, no septado. bolsa escrotal izquierda: cavidades escrotal distendida por presencia de extensa loe de aprox. 70 × 73 × 100 mm de ejes ap, tr y cc respectivamente, ovalada, de contornos bien delimitados, con predominio de hiperseñal en t1 y sin captacion significativa de contraste endovenoso, altamente sugestiva de hematoma organizado, observando areas en su interior geograficas con restriccion a la difusion que podrian sugerir coagulos. el teste izquierdo se observa con dificultad y parece estar disminuido de tamaño (10 × 27 mm) aparentemente comprimido y desplazado en sentido posterior, con irregularidad en su polo posterior, laceracion? a valorar antecedente traumatico. - paracentesis diagnostica (12/06) blanca -hemocultivos: negativos hasta el alta -sedimento orina 1-3 leucos/ campo -pcr covid19 (13/06) negativo orientacion diagnostica 1.- hemorragia digestiva alta por varices esofagicas. ligadura con bandas elasticas. cirrosis hepatica alcoholica child b. meld 17 puntos paciente con antecedente de cirrosis hepatica alcoholica que ingresa por vomitos en posos de cafe sin inestabilidad hemodinamica asociada. se realiza gastroscopia urgente en la que se observan varices esofagicas grandes y erosion en una de ellas, se procede a colocacion de bandas elasticas. se inicia tratamiento medico con somatostatina a dosis doble inicialmente y posteriormente a dosis habituales durante 5 dias en total y se inicia tratamiento con carvedilol 6.25mg: 1-0-1.5 sin incidencias. durante el ingreso se inicio tratamiento antibiotico profilactico con ceftriaxona 1gr/dia iv , profilaxis para encefalopatia hepatica con lactulosa oral y profilaxis de sd de abstinencia. se realizo ecografia abdominal sin loes hepaticas ni trombosis del eje esplenoportal. dada la estabilidad hemodinamica, adecuada tolerancia oral y ausencia de melenas o vomitos en posos de cafe se decide alta hospitalaria. 2.- anemia aguda secundaria a 1 hb 8,4g/dl inicial con descenso hasta hb 6,4 g/ dl requiriendo 2 concentrados de hematies. al alta hb 8.3 g/ dl 3.- ascitis grado i y edemas pretibiales. cirrosis hepatica enolica child pugh b7 pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 3 de 5 informe alta hospitalitzacio en este ingreso desarrolla liquido libre tipo i (paracentesis blanca) y edemas en eeii inciandose espironolactona 50 mg/ 24 h. 4.- trastorno dependencia alcoholica enolismo activo hasta el ingreso. durante el ingreso ha realizado deshabituacion farmacologica con clometiazol. no ha presentado sintomas de abstinencia. se le ofrece vinculacion con centro de deshabituacion / ccee psiquiatria para mantener abstinencia, pero el paciente lo rechaza por el momento. 5.- rao resuelta durante el ingreso. valorado por urologia quienes recomiendan inicio de tamsulosina 0.4mg/dia 6.- febricula sin foco. ulltimos dias ingresado presenta una febricula sin foco y con buen estado clinico. hc y uc negativos. pcr covid 19 negativo y paracentesis blanca. sin nuevos episodios de febricula 24 horas previas al alta. 7.- masa testicular izquierda a estudio se completa estudio durante el ingreso mediante rmn obteniendo imagenes compatibles con hematoma organizado. seguira controles de forma ambulatoria por urologia recomendaciones y tratamiento al alta - abstinencia absoluta de alcohol - dieta baja en sal - control de peso, tensiones arteriales y frecuencias cardiacas - acfol 1c/ dia durante un mes - ferro-sanol 1c/ dia (las deposiciones seran de color negruzcas) durante 1 mes - hidroxil b1-b6-b12 1c/ 12 h durante un mes - carvedilol 6,25 mg 1-0-1,5 - espironolactona 100 mg 1-0-0 - furosemida 40 mg 1-0-0 - lactulosa: 1 sobre al dia. suspender si diarreas - tamsulosina 0,4mg, 1-0-0 control - control y seguimiento en consulta ch intensivo (dra martin) previa analitica - control y seguimiento en urologia - se programa 2º sesion de ligadura de varices esofagicas tipus d'ingres: urgent motiu d'alta: alt.med.domicil metge adjunt: , pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 4 de 5 informe alta hospitalitzacio data informe: 15.06.2023 pacient cip data naix. 15.08.1958 edat 64 sexe home nass adreça cp poblacio tel. admissio 07.06.2023 11:52 alta 15.06.2023 12:29 data i hora d'impressio: 17.06.2023 05:01:07 pagina 5 de 5 informe alta hospitalitzacio\""
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "from nltk.corpus import stopwords\n",
    "\n",
    "stopwords = set(stopwords.words('spanish'))\n",
    "\n",
    "def remove_stopwords(text, stopwords=stopwords):\n",
    "    tokens = nltk.word_tokenize(text)\n",
    "    tokens = [word for word in tokens if word.lower() not in stopwords]\n",
    "    return ' '.join(tokens)\n",
    "\n",
    "train_data['Text'] = train_data['Text'].apply(remove_stopwords, stopwords=stopwords)\n",
    "\n",
    "train_data['Summary'] = train_data['Summary'].apply(remove_stopwords, stopwords=stopwords)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "text = train_data['Text'][1]\n",
    "summary = train_data['Summary'][1]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.13100308158753265"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "vectorizer = TfidfVectorizer()\n",
    "\n",
    "tfidf_matrix = vectorizer.fit_transform([train_data['Text'][0], train_data['Summary'][0]])\n",
    "cosine_similarity(tfidf_matrix[0:1], tfidf_matrix[1:2])[0][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "prova = \"\"\"Paciente varón de 58 años con antecedentes de trastorno de dependencia al alcohol, hiperlipidemia, hipertensión arterial, neumonía comunitaria, cirugía, neoplasia de mama, colecistectomía, entre otros. Ingresó por vómitos en contexto deglución. Presentaba vómitos autol, náuseas, fiebre, disnea, síndrome confus\n",
    "\n",
    "Durante su estancia en mi hospital, experimentó una buena evolución favorable, permaneciendo afebril, resolviendose el dolor y siendo dado deambular. Se retiró laxante y paso a vía oral. Los análisis mostraron una leve elevación de\n",
    "En el tercer trimestre se evidenfermedad cerebrovascular, objetivando hiponatremia, erc estadio 4 probablemente secundarias a cambios inflamatorios. El diagnóstico orientativo de infarto agudo\n",
    "El paciente evolucionó favorablemente tras el tratamiento deplectivo, manteniendo una adecuada adherencia al tratamiento antibiótico y\n",
    "Se trasladó a unidad de patología neuromuscular para continuar estudios de cirugía vascular, donde se establecieron pautas de tratamiento y digoxina, metasedimetasona, insulina, sertralina, metamizumab, foster\n",
    "Al alta se ajustó su tratamiento, retirando la pauta de insulina Lantomepron, venoclips, bromuromicina, metoclopramida, mycostatin, atrovent nebul\n",
    "La paciente fue capaz de una reunión con el equipo de atención primaria y especialistas endocrinología e infectología, identificando problemas de salud que requerían un manejo integral y un tratamiento multidisciplinario. La impresión diagnóstica\n",
    "Tras el diagnóstico de infección por COVID-procedentes de enfermedades infecciosas,se decidió iniciar tratamiento consistió en domicilio y recibir indicaciones claras para el manejo de su condición de manera de acuerdo con sus facultativos en sus\n",
    "Este resumen destaca los eventos clave en detallado el caso clínico\n",
    "Paciente masculino de 77 años que ingresó por\n",
    "Una historia clínica de múltiples comorbilidad que afectaba múltiples condiciones médicas crónicas, como EPOCAIT causat por adenocarcinoma irresectomía metabólico disematoso\n",
    " Además, hallazgos engrosamientos\n",
    "Sindrome ansioso\"\"\"\n",
    "\n",
    "\n",
    "predicted_text = remove_stopwords(prova, stopwords=stopwords)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Paciente varón 58 años antecedentes trastorno dependencia alcohol , hiperlipidemia , hipertensión arterial , neumonía comunitaria , cirugía , neoplasia mama , colecistectomía , . Ingresó vómitos contexto deglución . Presentaba vómitos autol , náuseas , fiebre , disnea , síndrome confus estancia hospital , experimentó buena evolución favorable , permaneciendo afebril , resolviendose dolor siendo dado deambular . retiró laxante paso vía oral . análisis mostraron leve elevación tercer trimestre evidenfermedad cerebrovascular , objetivando hiponatremia , erc estadio 4 probablemente secundarias cambios inflamatorios . diagnóstico orientativo infarto agudo paciente evolucionó favorablemente tras tratamiento deplectivo , manteniendo adecuada adherencia tratamiento antibiótico trasladó unidad patología neuromuscular continuar estudios cirugía vascular , establecieron pautas tratamiento digoxina , metasedimetasona , insulina , sertralina , metamizumab , foster alta ajustó tratamiento , retirando pauta insulina Lantomepron , venoclips , bromuromicina , metoclopramida , mycostatin , atrovent nebul paciente capaz reunión equipo atención primaria especialistas endocrinología infectología , identificando problemas salud requerían manejo integral tratamiento multidisciplinario . impresión diagnóstica Tras diagnóstico infección COVID-procedentes enfermedades infecciosas , decidió iniciar tratamiento consistió domicilio recibir indicaciones claras manejo condición manera acuerdo facultativos resumen destaca eventos clave detallado caso clínico Paciente masculino 77 años ingresó historia clínica múltiples comorbilidad afectaba múltiples condiciones médicas crónicas , EPOCAIT causat adenocarcinoma irresectomía metabólico disematoso Además , hallazgos engrosamientos Sindrome ansioso'"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "predicted_text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "import spacy\n",
    "word2vec = spacy.load('en_core_web_sm')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.9543169674954517 0.9256480468282452 0.9028793568361434\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\xavim\\AppData\\Local\\Temp\\ipykernel_16968\\42104694.py:6: UserWarning: [W007] The model you're using has no word vectors loaded, so the result of the Doc.similarity method will be based on the tagger, parser and NER, which may not give useful similarity judgements. This may happen if you're using one of the small models, e.g. `en_core_web_sm`, which don't ship with word vectors and only use context-sensitive tensors. You can always add your own word vectors, or use one of the larger models instead if available.\n",
      "  similarity = sent1.similarity(sent2)\n",
      "C:\\Users\\xavim\\AppData\\Local\\Temp\\ipykernel_16968\\42104694.py:7: UserWarning: [W007] The model you're using has no word vectors loaded, so the result of the Doc.similarity method will be based on the tagger, parser and NER, which may not give useful similarity judgements. This may happen if you're using one of the small models, e.g. `en_core_web_sm`, which don't ship with word vectors and only use context-sensitive tensors. You can always add your own word vectors, or use one of the larger models instead if available.\n",
      "  similarity2 = sent1.similarity(txt)\n",
      "C:\\Users\\xavim\\AppData\\Local\\Temp\\ipykernel_16968\\42104694.py:8: UserWarning: [W007] The model you're using has no word vectors loaded, so the result of the Doc.similarity method will be based on the tagger, parser and NER, which may not give useful similarity judgements. This may happen if you're using one of the small models, e.g. `en_core_web_sm`, which don't ship with word vectors and only use context-sensitive tensors. You can always add your own word vectors, or use one of the larger models instead if available.\n",
      "  similarity3 = sent2.similarity(txt)\n"
     ]
    }
   ],
   "source": [
    "txt = word2vec(text)\n",
    "\n",
    "sent1 = word2vec(summary)\n",
    "sent2 = word2vec(predicted_text)\n",
    "\n",
    "similarity = sent1.similarity(sent2)\n",
    "similarity2 = sent1.similarity(txt)\n",
    "similarity3 = sent2.similarity(txt)\n",
    "\n",
    "print(similarity, similarity2, similarity3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.10371067386864069"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "vectorizer = TfidfVectorizer()\n",
    "\n",
    "tfidf_matrix = vectorizer.fit_transform([summary, predicted_text])\n",
    "cosine_similarity(tfidf_matrix[0:1], tfidf_matrix[1:2])[0][0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[0.13100308158753265, 0.1285269508598975, 0.14675843491202195, 0.12558087064292936, 0.11440985265254486, 0.20355873941340802, 0.08155628194067321, 0.09957685918829998, 0.047495558815275576, 0.09747262509920113]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "import numpy as np\n",
    "\n",
    "\n",
    "vectorizer = TfidfVectorizer()\n",
    "\n",
    "# do it for all\n",
    "cosine_similarities = []\n",
    "\n",
    "for i in range(len(train_data)):\n",
    "    tfidf_matrix = vectorizer.fit_transform([train_data['Text'][i], train_data['Summary'][i]])\n",
    "    cosine_similarities.append(cosine_similarity(tfidf_matrix[0:1], tfidf_matrix[1:2])[0][0])\n",
    "\n",
    "print(cosine_similarities)\n",
    "\n",
    "plt.bar(range(len(cosine_similarities)), cosine_similarities)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.1809561651596761"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "\n",
    "vectorizer = CountVectorizer()\n",
    "\n",
    "count_matrix = vectorizer.fit_transform([summary, predicted_text])\n",
    "cosine_similarity(count_matrix[0:1], count_matrix[1:2])[0][0]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[0.21099802865973794, 0.20522769133562777, 0.23326502014993883, 0.20445959016024434, 0.18134828181801366, 0.3114840598909106, 0.1456985592771548, 0.1670382761952652, 0.08856148855400953, 0.16865480854231357]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "import numpy as np\n",
    "\n",
    "vectorizer = CountVectorizer()\n",
    "\n",
    "cosine_similarities = []\n",
    "\n",
    "for i in range(len(train_data)):\n",
    "    count_matrix = vectorizer.fit_transform([train_data['Text'][i], train_data['Summary'][i]])\n",
    "    cosine_similarities.append(cosine_similarity(count_matrix[0:1], count_matrix[1:2])[0][0])\n",
    "\n",
    "print(cosine_similarities)\n",
    "\n",
    "plt.bar(range(len(cosine_similarities)), cosine_similarities)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Histogram similarity between summary and text: 0.13976377952755906\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<BarContainer object of 239 artists>"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "#text = train_data['Text'][0]\n",
    "#summary = train_data['Summary'][0]\n",
    "\n",
    "\n",
    "# Tokenize text and summary\n",
    "text_tokens = nltk.word_tokenize(summary)\n",
    "summary_tokens = nltk.word_tokenize(predicted_text)\n",
    "\n",
    "# Compute unique words in text and summary\n",
    "unique_words_text = set(text_tokens)\n",
    "unique_words_summary = set(summary_tokens)\n",
    "\n",
    "all_unique_words = unique_words_summary.union(unique_words_text)\n",
    "\n",
    "# Create histograms\n",
    "hist_summary = np.array([summary.lower().count(word) for word in all_unique_words])\n",
    "hist_text = np.array([text.lower().count(word) for word in all_unique_words])\n",
    "\n",
    "# Compute histogram intersection\n",
    "intersection = np.minimum(hist_summary, hist_text)\n",
    "intersection_sum = np.sum(intersection)\n",
    "\n",
    "# Compute histogram lengths\n",
    "length_summary = np.sum(hist_summary)\n",
    "length_text = np.sum(hist_text)\n",
    "\n",
    "# Compute histogram similarity (intersection over union)\n",
    "similarity = intersection_sum / (length_summary + length_text - intersection_sum)\n",
    "\n",
    "print(\"Histogram similarity between summary and text:\", similarity)\n",
    "\n",
    "#plot the 3 histograms\n",
    "\n",
    "plt.figure(figsize=(10, 5))\n",
    "\n",
    "plt.bar(range(len(all_unique_words)), hist_summary, alpha=0.5, label='Summary')\n",
    "plt.bar(range(len(all_unique_words)), hist_text, alpha=0.5, label='Text')\n",
    "plt.bar(range(len(all_unique_words)), intersection, alpha=0.5, label='Intersection')\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Histogram similarity between summary and text: 0.11224489795918367\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 2000x1000 with 3 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "import numpy as np\n",
    "\n",
    "#text = train_data['Text'][0]\n",
    "#summary = train_data['Summary'][0]\n",
    "\n",
    "\n",
    "# Tokenize text and summary\n",
    "summ = nltk.word_tokenize(summary)\n",
    "predicted = nltk.word_tokenize(predicted_text)\n",
    "\n",
    "# Compute unique words in text and summary\n",
    "unique_words_summ = set(summ)\n",
    "unique_words_predicted = set(predicted)\n",
    "\n",
    "all_unique_words = unique_words_predicted.union(unique_words_summ)\n",
    "\n",
    "# Create histograms\n",
    "hist_summ = np.array([summary.lower().count(word) for word in all_unique_words])\n",
    "hist_predicted = np.array([predicted_text.lower().count(word) for word in all_unique_words])\n",
    "\n",
    "# Compute histogram intersection\n",
    "intersection = np.minimum(hist_summ, hist_predicted)\n",
    "intersection_sum = np.sum(intersection)\n",
    "\n",
    "# Compute histogram lengths\n",
    "length_summ = np.sum(hist_summ)\n",
    "length_predicted = np.sum(hist_predicted)\n",
    "\n",
    "# Compute histogram similarity (intersection over union)\n",
    "similarity = intersection_sum / (length_summ + length_predicted - intersection_sum)\n",
    "\n",
    "print(\"Histogram similarity between summary and text:\", similarity)\n",
    "\n",
    "#plot the 3 histograms in different figures\n",
    "plt.figure(figsize=(20, 10))\n",
    "plt.subplot(3, 1, 1)\n",
    "plt.bar(range(len(hist_summ)), hist_summ)\n",
    "plt.title(\"Summary histogram\")\n",
    "plt.subplot(3, 1, 2)\n",
    "plt.bar(range(len(hist_predicted)), hist_predicted)\n",
    "plt.title(\"Predicted histogram\")\n",
    "plt.subplot(3, 1, 3)\n",
    "plt.bar(range(len(intersection)), intersection)\n",
    "plt.title(\"Intersection histogram\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[{'rouge-1': {'r': 0.15294117647058825, 'p': 0.0783132530120482, 'f': 0.10358565289122415}, 'rouge-2': {'r': 0.04081632653061224, 'p': 0.018957345971563982, 'f': 0.02588996330620824}, 'rouge-l': {'r': 0.1411764705882353, 'p': 0.07228915662650602, 'f': 0.0956175254011843}}]\n",
      "BLEU = 1.77 12.4/1.8/0.9/0.5 (BP = 1.000 ratio = 2.037 hyp_len = 218 ref_len = 107)\n"
     ]
    }
   ],
   "source": [
    "# compute rouge score\n",
    "from rouge import Rouge\n",
    "\n",
    "rouge = Rouge()\n",
    "\n",
    "scores = rouge.get_scores(predicted_text, summary)\n",
    "print(scores)\n",
    "\n",
    "\n",
    "import sacrebleu\n",
    "\n",
    "bleu = sacrebleu.corpus_bleu([predicted_text], [[summary]])\n",
    "\n",
    "print(bleu)\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "asho_nlp",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
